PMID: 9552186Apr 29, 1998Paper

Carriage of methicillin-resistant Staphylococcus aureus at hospital admission

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
N TroilletA W Karchmer

Abstract

To measure the prevalence of, and to establish predictors for, the nasal carriage of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission. To evaluate mannitol-salt agar with oxacillin for the simultaneous detection and identification of MRSA from nasal swabs. Three-month prospective case-control survey, with data collected from interviews and computerized databases. The criterion standard for MRSA detection was culture on Mueller-Hinton agar with oxacillin 6 microg/mL (National Committee for Clinical Laboratory Standards method). 320-bed tertiary-care hospital. 387 patients screened within 24 hours after admission, including 10 MRSA carriers (cases), 291 patients with no S aureus, and 86 patients with methicillin-susceptible S aureus. The prevalence of MRSA nasal carriage was 2.6%, whereas the prevalence of carriage was 3.1% when both nasal and wound cultures were performed. The significant predictors of carriage were a prior detection of MRSA, open wounds, diabetes mellitus, treatments by injection, prior nursing home stays, visits at home by a nurse, and prior antibiotic treatments. Cases had stayed for longer periods in hospitals and had received longer antibiotic treatments within a year. Eighty patient...Continue Reading

Citations

Nov 16, 2002·Current Infectious Disease Reports·Fu-Yu Chiang, Michael Climo
Aug 7, 2003·The Lancet Infectious Diseases·Allison E Aiello, Elaine Larson
Apr 24, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A ScanvicJ C Lucet
Jan 18, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Edwin D CharleboisFrançoise Perdreau-Remington
Jan 11, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Cassandra D SalgadoDavid P Calfee
May 25, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·E S Dodds AshleyK S Kaye
Jun 29, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alicia I HidronMark D King
Oct 9, 2007·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Efraim AizenIsrael Potasman
Mar 17, 2004·Advances in Skin & Wound Care·Maryanne McGuckin
Oct 11, 2005·Critical Care Medicine·Cassandra D SalgadoBarry M Farr
Mar 2, 2002·The Lancet Infectious Diseases·B M FarrR J Sherertz
Aug 14, 2008·The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland·K HassanS Giles
Feb 24, 2006·The American Journal of Medicine·Stephan HarbarthDidier Pittet
Jul 31, 2008·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Deverick J AndersonKeith S Kaye
Jul 10, 2016·Clinics in Geriatric Medicine·Ana MontoyaLona Mody
Aug 16, 2016·Infectious Disease Clinics of North America·Elaine FlanaganLona Mody
Dec 11, 2007·American Journal of Infection Control·Jane D SiegelUNKNOWN Healthcare Infection Control Practices Advisory Committee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
A GoetzR R Muder
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
B D Graeber
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
G PapiaA E Simor
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
E GirouC Brun-Buisson
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
S Harbarth, D Pittet
© 2022 Meta ULC. All rights reserved